
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Protolichesterinic Acid
CAS:Formula:C19H32O4Color and Shape:White To Off-White SolidMolecular weight:324.46(1S)-(+)-10-Camphorsulfonic Acid
CAS:Controlled ProductStability Hygroscopic Applications Used as a resolving agent, and as a catalyst for coupling dipeptides. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the packageFormula:C10H16O4SColor and Shape:NeatMolecular weight:232.302-epi-Darunavir
CAS:Applications 2-epi-Darunavir is a stereoisomer to Darunavir (D193500), a second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral. It is a COVID19-related research product. References Rao, R.N., et. al.: J. Sep. Sci., 35, 2671 (2012); Koh, Y., et al.: Antimicrob. Agents Chemother., 47, 3123 (2003); Arasteh, K., et al.: AIDS, 19, 943 (2005); Surleraux, D.L.N.G., et al.: J. Med. Chem., 48, 1813 (2005)Formula:C27H37N3O7SColor and Shape:NeatMolecular weight:547.663-Oxo-4-aza-5α-androst-1-ene-17β-carboxylic Acid
CAS:Formula:C19H27NO3Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:317.43Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzyloxycarbonyl-L-valinate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H26N6O6Color and Shape:White Crystalline PowderMolecular weight:458.19138Hydroxyhomo Sildenafil
CAS:Formula:C23H32N6O5SColor and Shape:White To Off-White SolidMolecular weight:504.61Glycodeoxycholic Acid
CAS:Formula:C26H43NO5Color and Shape:White To Off-White SolidMolecular weight:449.63Ref: 4Z-C-487003
Discontinued productSalicylic Acid-d4
CAS:Controlled ProductFormula:C72H4H2O3Color and Shape:White To Off-WhiteMolecular weight:142.15Edoxaban Impurity 31
Formula:C9H9ClN2O3Color and Shape:White To Off-White SolidMolecular weight:228.63Hydroxy Vardenafil
CAS:Formula:C23H32N6O5SColor and Shape:White To Off-White SolidMolecular weight:504.61Loxapine Related Compound A (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H18ClN3OColor and Shape:Yellow Crystalline PowderMolecular weight:327.11384rel-(R,R)-Voriconazole
CAS:Controlled ProductApplications The (R,R)-enantiomer of Voriconazole. An antifungal (systemic). An ergosterol biosynthesis inhibitor. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Sanati, H., et al.: Antimicrob. Ag. Chemother., 41, 2492 (1997),Formula:C16H14F3N5OColor and Shape:NeatMolecular weight:349.31(Z)-Methyl 2-((tert-Butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)acrylate
CAS:Controlled ProductFormula:C18H24N2O5Color and Shape:NeatMolecular weight:348.39Vidarabine
CAS:Formula:C10H13N5O4Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:267.25